March 23, 2025: In-Person Meet & Greet in Roseville, CA

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event on Sunday, March 23, from 3:30 to 5:30 p.m PT. Hosted by AFTD volunteer and caregiver Ed Fargusson and AFTD Ambassador Terry Walter, this event will take place at the Seventh Day Adventist Conference Center at 2100…

Read More

Roseville, CA In-Person Meet & Greet

Join and learn from others who understand the FTD journey at this in-person AFTD Meet & Greet event hosted by AFTD volunteer and caregiver Ed Fargusson and AFTD Ambassador Terry Walter. RSVP for this event by contacting Terry by email (twalter@theaftd.org) or phone (916-761-7180). We encourage you to download this flyer and share it with…

Read More

Statement from The Association for Frontotemporal Degeneration (AFTD) on Disruption of Scientific Research Funding and Activities

Text: Statement from The Association for Frontotemporal Degeneration on Disruption of Scientific Research Funding and Activities

The Association for Frontotemporal Degeneration (AFTD) is deeply concerned about recent policy changes and layoffs at the National Institutes of Health (NIH) that greatly disrupt biomedical research of high importance to the families we serve. FTD is the most common dementia diagnosed in people under 60 years and currently has no effective treatment. Many families…

Read More

AFTD Webinar: At the Intersection of FTD and the Law

FTD can present with executive dysfunction, impulsivity, loss of empathy, apathy, and disinhibition. At times, these symptoms can lead to interactions with police, whether responding to an incident at home or in the community resulting in an arrest. This webinar highlights what we know about the incidence of these interactions, discusses what FTD symptoms are…

Read More

AFTD Webinar: AFTD and You — Partners in Drug Development

How does a great scientific idea become an effective treatment? It’s a long and complicated process! Drug development involves many key players, including researchers, companies, regulators, funders, patient advocacy organizations like AFTD and, importantly, community members with lived experience of FTD. The field of FTD has made exciting progress in the past decade, with treatments…

Read More